Abstract
Edvard Abel, Ewa Silander, Jan Nyman, Mogens Bove, Leif Johansson, Thomas Björk-Eriksson, Eva Hammerlid
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site
10.1016/j.radonc.2011.05.036 · 2011
Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis
10.1016/s0140-6736(06)69121-6 · 2006
A prospective study of quality of life in head and neck cancer patients. Part I: At diagnosis
10.1097/00005537-200104000-00021 · 2001
Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer
10.1016/j.ijrobp.2007.04.021 · 2007
Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy
10.1200/jco.2007.14.6647 · 2008
Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation
10.1002/hed.20427 · 2006
Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls
10.1200/jco.2005.04.7225 · 2006
The radioresponsiveness of human tumours and the initial slope of the cell survival curve
10.1016/s0167-8140(84)80074-2 · 1984
Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy
10.1016/0360-3016(81)90377-1 · 1981
Posttreatment quality-of-life assessment in patients with head and neck cancer treated with intensity-modulated radiation therapy
10.1097/coc.0b013e3181f4759c · 2011
Intensity-modulated radiotherapy is associated with improved global quality of life among long-term survivors of head-and-neck cancer
10.1016/j.ijrobp.2011.11.026 · 2012
Parotid-Sparing Intensity Modulated versus Conventional Radiotherapy in Head and Neck Cancer (PARSPORT): A phase 3 multicentre randomised controlled trial
10.1016/s1470-2045(10)70290-4 · 2011
Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: Results of a nonrandomized prospective study using a standardized follow-up program
10.1016/j.ijrobp.2008.07.059 · 2009
Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study
10.1016/j.ijrobp.2007.12.054 · 2008
The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
10.1093/jnci/85.5.365 · 1993
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group
10.1016/s0959-8049(00)00186-6 · 2000
Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
10.1200/jco.1999.17.3.1008 · 1999
Unresolved referenced work
2001
Interpreting the significance of changes in health-related quality-of-life scores
10.1200/jco.1998.16.1.139 · 1998
Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report
10.1016/j.ijrobp.2005.02.045 · 2005
Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: Matched-pair comparison with conventional radiotherapy
10.1016/j.ijrobp.2006.11.012 · 2007
Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma
10.1016/j.ijrobp.2007.05.003 · 2007
Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life
10.1186/1748-717x-3-41 · 2008
10.1016/j.oraloncology.2013.02.013
10.1016/j.oraloncology.2013.02.013 · 2013
Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy
2016
Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life
1999
Dose-response analysis of parotid gland function: what is the best measure of xerostomia?
10.1016/j.radonc.2013.03.009 · 2013
Use of normal tissue complication probability models in the clinic
10.1016/j.ijrobp.2009.07.1754 · 2010
No additional external references are available.